Primary Care/Hospitalist
RSSArticles
-
Pharmacology Watch - Full December 2011 Issue in PDF
-
Treatment of essential tremor
-
HPV vaccine and anal cancer risk
-
FDA Actions
-
Abstract & Commentary: Otoscopic Signs of Otitis Media
A total of 783 children 6-24 months of age were followed for an entire respiratory season by four experienced otoscopists using pneumatic otoscopy of one ear, randomly selected for each child. -
Abstract & Commentary: Moxifloxacin for Odontogenic Infection
Outpatients with a diagnosis of either dentoalveolar or periodontal abscess or a diagnosis of gingival inflammatory infiltrates were randomized to receive either moxifloxacin 400 mg daily or clindamycin 300 mg QID, both for 5 days, in a prospective, randomized, placebo-controlled, double-dummy clinical trial design. -
Abstract & Commentary: Effect of an Oxazolidinone and Clindamycin on Staphylococcus aureus Virulence Factors
Baseline production of PSMa subtypes was examined in 50 PVL-positive methicillin-susceptible Staphylococcus aureus (MSSA) and MRSA clinical isolates using liquid chromatography-tandem mass spectrometry (LC-MS-MS), and these results were compared to a control strain, LAC (USA300). MICs were determined using a broth macrodilution method. -
Abstract & Commentary: Intravenous Immune Globulin for Neonatal Sepsis
A double-blind, randomized, controlled trial conducted by the International Neonatal Immunotherapy Study (INIS) compared adjunctive therapy of human nonspecific polyvalent IgG intravenous immune globulin to placebo in the treatment of newborn infants with suspected or proven sepsis who were also receiving antibiotic therapy. -
Abstract & Commentary: HIV-1 Protein, Nef, Contributes to Insulin Resistance
While a number of antiretroviral agents have been implicated in contributing to both insulin resistance and lipid abnormalities, HIV also directly causes metabolic disturbances. -
Clinical Briefs in Primary Care supplement